Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/16698
Título
Semaglutide treatment attenuates vessel remodelling in ApoE-/- mice following vascular injury and blood flow perturbation.
Autor(es)
Jensen, Ditte Marie | Skovsted, Gry Freja | Bonde, Mathilde Frederikke Bjørn | Bentzon, Jacob Fog | Rolin, Bidda | Franck, Grégory | Ougaard, Maria Katarina Elm | Voetmann, Louise Marie | Bachmann, Julian Christoffer | Uryga, Anna | Pyke, Charles | Kirk, Rikke Kaae | Hvid, Henning | Knudsen, Lotte Bjerre | Lykkesfeldt, Jens | Nyberg, Michael
Fecha de publicación
2022-08
Cita
Atheroscler Plus. 2022 Jun 4:49:32-41.
Idioma
Inglés
Tipo de documento
journal article
Resumen
BACKGROUND AND AIMS
Randomized clinical studies have shown a reduction in cardiovascular outcomes with glucagon-like peptide 1 receptor agonist (GLP-1RA) treatment with the hypothesized mechanisms being an underlying effect on atherosclerosis. Here, we aimed to assess the pharmacological effects of semaglutide in an atheroprone murine model that recapitulates central mechanisms related to vascular smooth muscle cell (VSMC) phenotypic switching and endothelial dysfunction known to operate within the atherosclerotic plaque.
METHODS
In study A, we employed an electrical current to the carotid artery in ApoE-/- mice to induce severe VSMC injury and death, after which the arteries were allowed to heal for 4 weeks. In study B, a constrictive cuff was added for 6 h at the site of the healed segment to induce a disturbance in blood flow.
RESULTS
Compared to vehicle, semaglutide treatment reduced the intimal and medial area by ∼66% (p = 0.007) and ∼11% (p = 0.0002), respectively. Following cuff placement, expression of the pro-inflammatory marker osteopontin and macrophage marker Mac-2 was reduced (p < 0.05) in the semaglutide-treated group compared to vehicle. GLP-1R were not expressed in murine carotid artery and human coronary vessels with and without atherosclerotic plaques, and semaglutide treatment did not affect proliferation of cultured primary human VSMCs.
CONCLUSIONS
Semaglutide treatment reduced vessel remodelling following electrical injury and blood flow perturbation in an atheroprone mouse model. This effect appears to be driven by anti-inflammatory and -proliferative mechanisms independent of GLP-1 receptor-mediated signalling in the resident vascular cells. This mechanism of action may be important for cardiovascular protection.
Versión en línea
DOI
Aparece en las colecciones
Ficheros en el ítem
![Acceso Abierto Acceso Abierto](/themes/Mirage2/images/openAccess.png)
- Nombre:
- Semaglutide treatment_Atheroscler ...
- Tamaño:
- 2.804Mb
- Formato:
- Descripción:
- Artículo